Description

A blend combining BPC-157 and TB-500 for laboratory investigation of peptide combinations and related biological pathways. For laboratory use only; not for human or veterinary use.

Product overview

Wolverine combines BPC-157 and TB-500. BPC-157 has been investigated in rat tendon fibroblasts, while thymosin beta-4 has been studied in animal wound models. These are studies of individual compounds, not controlled trials of the Wolverine blend.

Published thymosin beta-4 findings cannot automatically be applied to a product labelled TB-500 without confirming its molecular identity. Component amounts, identity and batch testing should be checked against the product label and available documentation.

References

Read the original publications for methods, limitations and the preparation studied.

  1. Chang et al., 2014: BPC-157 in rat tendon fibroblasts (PMID 25415472)
  2. Malinda et al., 1999: thymosin beta-4 in a rat wound model (PMID 10469335)

Dosage: 10mg

Certificate of Analysis

Original laboratory reports for BPC-157 5mg + TB-500 5mg — Wolverine 10mg. Documents are listed by report date. Findings apply to the individual samples tested; refer to each original report for its results.

Verify this batch

Print or download (PDF)

Dosage: 20mg

Certificate of Analysis

Original laboratory reports for BPC-157 10mg + TB-500 10mg — Wolverine 20mg. Documents are listed by report date. Findings apply to the individual samples tested; refer to each original report for its results.

Verify this batch

Print or download (PDF)